» Articles » PMID: 22660803

Persistent or New Onset Microscopic Hematuria in Patients with Small Vessel Vasculitis in Remission: Findings on Renal Biopsy

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 2012 Jun 5
PMID 22660803
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Hematuria is considered a sign of active renal disease in patients with small-vessel vasculitis. In patients who are in apparent clinical remission, presence of persistent or new-onset microscopic hematuria may reflect active vasculitis, damage, or other glomerular pathology.

Methods: We identified 74 patients from the Johns Hopkins Renal Pathology database between 1995 and 2009 with the diagnosis of pauciimmune glomerulonephritis (GN). Among them we identified 9 who were in clinical remission and underwent a renal biopsy for evaluation of persistent or new-onset hematuria.

Results: Nine patients with small-vessel vasculitis, 8 antineutrophil cytoplasmic antibody (ANCA)-positive and 1 ANCA-negative, underwent a renal biopsy at variable time periods after remission of vasculitis (6 to 164 months) for persistent microscopic hematuria (n = 6) or new-onset microscopic hematuria (n = 3). All patients were in apparent clinical remission at the time of renal biopsy. Of the 3 patients presenting with new-onset hematuria, 2 had crescentic IgA nephropathy and 1 had healed crescentic pauciimmune GN. Of the 6 patients with persistent hematuria, 2 had arteriosclerosis, 2 had focal segmental glomerulosclerosis, and 2 had global and segmental glomerulosclerosis and healed crescentic GN, and none had active vasculitis.

Conclusion: Microscopic hematuria in patients with renal vasculitis otherwise in remission could represent chronic glomerular injury from prior episode of vasculitis or may represent new glomerular pathology. Renal biopsy should be considered in these patients to guide therapy.

Citing Articles

Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis.

Chalkia A, Jones R, Smith R, Willcocks L, Jayne D Clin Kidney J. 2025; 18(1):sfae379.

PMID: 40008353 PMC: 11852340. DOI: 10.1093/ckj/sfae379.


Urinary CD4 + T Cells Predict Renal Relapse in ANCA-Associated Vasculitis.

Prskalo L, Skopnik C, Goerlich N, Freund P, Wagner L, Grothgar E J Am Soc Nephrol. 2024; 35(4):483-494.

PMID: 38231590 PMC: 11000730. DOI: 10.1681/ASN.0000000000000311.


Challenges of defining renal response in ANCA-associated vasculitis: call to action?.

Odler B, Bruchfeld A, Scott J, Geetha D, Little M, Jayne D Clin Kidney J. 2023; 16(6):965-975.

PMID: 37261001 PMC: 10229283. DOI: 10.1093/ckj/sfad009.


Prognostic value of proteinuria monitoring in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Lee Y, Ahn S, Oh J, Kim Y, Lee C, Yoo B Clin Exp Nephrol. 2023; 27(8):672-679.

PMID: 37095345 DOI: 10.1007/s10157-023-02352-y.


Urinary T Cells Identify Renal Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Predict Prognosis: A Proof of Concept Study.

Sonnemann J, Klocke J, Bieringer M, Rousselle A, Eckardt K, Elitok S Kidney Int Rep. 2023; 8(4):871-883.

PMID: 37069968 PMC: 10105048. DOI: 10.1016/j.ekir.2023.01.013.